logo

For the Inventor, By the Inventor

Telangana, India

Msn Laboratories Private Limited


USPTO Granted Patents = 30

% Expired Patents = 76.7


Forward Citations = 41

Loading Chart...
Loading Chart...

34 inventors (with patents filed for the assignee):

goldMedal Srinivasan Thirumalai Rajan (18 out of 20 patents)

silverMedal Sajja Eswaraiah (16 out of 19 patents)

bronzeMedal Manne Satyanarayana Reddy (14 out of 24 patents)

4.  Thirumalai Rajan Srinivasan (6 out of 16 patents)

5.  Eswaraiah Sajja (6 out of 18 patents)

6.  Venkat Reddy Ghojala (5 out of 7 patents)

7.  Revu Satyanarayana (4 out of 4 patents)

8.  Maramreddy Sahadeva Reddy (4 out of 4 patents)

9.  Muppa Kishore Kumar (4 out of 7 patents)

10.  Rajesham Boge (3 out of 10 patents)

11.  Gutta Madhusudhan (3 out of 3 patents)

12.  Chakilam Nagaraju (3 out of 4 patents)

13.  Achampeta Kodanda Ramprasad (3 out of 3 patents)

14.  Rajeshwar Reddy Sagyam (2 out of 11 patents)

15.  Venkata Panakala Rao Gogulapati (2 out of 5 patents)


Core Competencies:
Pharmaceuticals
Benzimidazole
Statins
Antifungal
Polymorphs
Intermediates
Duloxetine
Montelukast
Ezetimibe
Processes
Crystalline Forms
Preparation

30 patents:

1. 11279696 - Processes for the preparation of 7-{4-[4-(1-benzothiophen-4-yl) piperazin-1-yl]butoxy}quinolin-2(1H)-one (2022-03-22),
2. 10913762 - Process for the preparation of D-glucitol, 1,5-anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl] oxy]phenyl] methyl] phenyl]-, (1S) and its crystalline forms thereof (2021-02-09),
3. 10913717 - Solid state forms of N-[2-[(I S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methyl sulfonyl)ethyl]-2,3-dihydro-1,3-dioxo-L H-isoindol-4-yl]acetamide and process for preparation thereof (2021-02-09),
4. 10703731 - Process for the preparation of Trisodium (4- {[1S,3R)-1-([1,1'-biphenyl]-4-ylmethyl)-4-ethoxy-3-methyl-4-oxobutyl]amino}-4-oxobutanoate)-(N-petanoyl-N-{[2′-(1H-tetrazol-1-1D-5-yl)[1,1′-biphenyl]-4-yl]methyl}- L-valinate) and its polymorphs thereof (2020-07-07),
5. 10633390 - Process for the preparation of [(1S,2R)-3-[[(4-aminophenyl)sulfonyl] (2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-carbamic acid (3R,3AS,6AR)hexahydro furo [2,3-B]furan-3-YL ester and its amorphous form (2020-04-28),
6. 10633372 - Process for the preparation of amorphous (1S)-1,5-anhydro-1-[3-[[5-(4 fluorophenyl)-2-thienyl]-4-methylphenyl]-D-glucitol and its polymorphs thereof (2020-04-28),
7. 10562931 - Process for the preparation of (1S, 4S, 7Z, 10S, 16E, 21R)-7-ethyldene-4,21-bis(1-methyl-ethyl)-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo[8.7.6]tricos-16-ene-3, 6, 9, 19, 22-pentone (2020-02-18),
8. 10550107 - Process for the preparation of N-[4-[(3-chloro-4-fluoro phenyl) amino]-7-[[(3s-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethyl amino)-(2E)-2-butenamide (2Z)-2-butenedioate (1:2) and its polymorphs thereof (2020-02-04),
9. 10544189 - Process for the preparation of (2S)-N-((S)-1-((S)-4-methyl-1-((R)-2-methyl oxiran-2-yl)-1-oxopentan-2-ylcarbamoyl)-2-phenylethyl)-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)-4-methylpentanamide (2020-01-28),
10. 10544097 - Solid state forms of N-[2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]acetamide and process for preparation thereof (2020-01-28),
11. 10351556 - Process for the preparation of 1,3-thiazol-5-ylmethyl [(2R,5R)-5-{[(2s)-2-[(methyl{[2-(propan-2-yl)-1,3-thiazol-4YL] methyl} carbamoyl) amino]-4-(morpholin-4-yl)butanoyl]amino)-1,6-diphenylhexan-2-yl]carbamate (2019-07-16),
12. 10301302 - Crystalline forms of N-(2-chloro-6-methy]phenvn-2-[F6-[4-(2-hvdroxvethvl)-L-piperazin-vil-2-methvil-4-pvrimidinvllaminol-5-thiazolecarboxamide and their process thereof (2019-05-28),
13. 10144710 - Process for the preparation of 4-[-({[4-choloro-3(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-N-methylpyridine-2-carboxamide and its polymorphs thereof (2018-12-04),
14. 10093625 - Process for the preparation of [[2(S)-[[4(R)-(3-hydroxyphenyl)-3(R),4-dimethyl-1-piperidinyl]methyl]-1-oxo-3-phenylpropyl]amino]acetic acid dihydrate (2018-10-09),
15. 9718779 - Intermediate and polymorphs of 1-(4-methoxypheny1)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetra hydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide and process thereof (2017-08-01),
Msn Laboratories Private Limited is a prominent player in the pharmaceutical industry, specializing in the development and manufacturing of a wide range of generic and specialty medications. The company is focused on research and innovation, particularly in the fields of active pharmaceutical ingredients (APIs) and finished dosage forms. Based in Telangana, India, Msn Laboratories is committed to enhancing healthcare through quality products and advanced technologies, catering to both domestic and international markets.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

Msn Laboratories Private Limited
30 Patents

#1 in Telangana

#70 in India

#21,840 in the World

Telangana, IN
Telangana, India

Msn Laboratories Private Limited

Forward Citations = 41

34 inventors:

goldMedal Srinivasan Thirumalai Rajan (18 out of 20 patents)

silverMedal Sajja Eswaraiah (16 out of 19 patents)

bronzeMedal Manne Satyanarayana Reddy (14 out of 24 patents)

4.  Thirumalai Rajan Srinivasan (6 out of 16 patents)

5.  Eswaraiah Sajja (6 out of 18 patents)

Please report any incorrect information to [email protected]
Loading…